Introduction

Background
Intensive care unit (ICU)-acquired infections are associated with increased mortality, morbidity, and healthcare costs. An overall infection rate of 46%-60% has been reported (1) . ICU-acquired infections are associated with a doubling in risk of hospital death (2) . The mortality rate has been reported to be as high as 70% (3) . Factors such as disease severity, comorbid conditions, indwelling catheterization, and age have been studied as risk factors for infection in ICU patients (4, 5) .
Recently, vitamin D has been shown to play an essential role in modulating the immune response (6, 7) . It stimulates the expression of antimicrobial peptides from monocytes, prevents excessive expression of inflammatory cytokines, and amplifies the effect of macrophages (8) .
Vitamin D is first metabolized in the liver to its major circulating metabolite, 25-hydroxyvitamin-D (25 (OH) D), and then in the kidneys to its active form, 1,25-(OH) 2 -D. 25 (OH) D reflects the total amount of vitamin better than other metabolites. It is measured to determine the status of vitamin D. Various definitions of insufficiency and deficiency have been established according to 25 (OH) D levels (9) .
In the last decade, studies have been performed to investigate the incidence of 25 (OH) D deficiency and its association with adverse outcomes among critically ill patients (10) (11) (12) (13) (14) (15) (16) (17) . Most studies have focused mainly on mortality. Growing evidence supports that 25 (OH) D deficiency is independently associated with short-and long-term mortality (18) (19) (20) . However, the relationship between vitamin D levels and ICU-acquired infections has not been well examined.
Therefore, we aimed to determine whether vitamin D deficiency (assessed by serum 25 (OH) D concentration) is a risk factor for nosocomial infections and mortality among critically ill patients. It was expected that patients with low levels of vitamin D would be more prone to infections and death. PLS was used to describe the patient's performance status prior to acute illness. We classified patients into four groups: unlimited activity, limited activity, homebound, and chair or bed-bound (21) .
Materials and methods
Study design and setting
Comorbid conditions documented in the past medical history were recorded according to ICD-10 coding. ICU-acquired infection was defined as an infection that developed more than 48 h after ICU admission and was diagnosed by an infection specialist who visited the patients every workday. Infections during the first 28 days, and the entire ICU stay, were recorded independently.
ICU, hospital, and 1-year mortality were recorded. If the patient was discharged from the hospital, information about 1-year mortality was obtained from the population registration system. Because there is no consensus on optimal 25 (OH) D levels among the ICU population, we categorized them into six different groups. The cutoff points were 5, 10, 15, and 20 ng/mL. We did not use higher cutoff levels because there were only 12 patients with 25 (OH) D levels higher than 25 ng/mL. 2.2. Statistical methods IBM SPSS Statistics version 22.0 (IBM Corp, Somers, NY, USA) was used for statistical analysis. Normality was assessed using the Kolmogorov-Smirnov test. Because all continuous data were nonnormally distributed, they were expressed as the median and interquartile range (IQR) and were compared using the Mann-Whitney U-test. Categorical data were expressed as the number (n) and percentage (%) of events and were compared by Pearson's chi-squared or Fisher's exact test. Data were analyzed at a confidence level of 95%. A P-value less than 0.05 was considered statistically significant.
We used binary logistic regression models to estimate unadjusted and adjusted odd ratios (ORs) of ICUacquired infections and mortality in different 25 (OH) D groups. ORs were adjusted for age, SAPS II, sex, season, comorbidities, PLS scores, and admission diagnosis. The "purposeful selection of variables" was used for the selection of covariates for logistic regression to create the best model (22) .
Multicategory covariates (season, comorbidities, PLS scores, and admission diagnosis) were specified as separate variables to exclude dummy categories. Adjusted residuals in the chi-squared test were used to determine the significance category. Therefore, final covariates with a P-value greater than 0.25 were selected for the pre-model. The variables that were not significant in this multivariate model at the 0.1 alpha level were removed in subsequent steps. If the removing variable changed the estimated OR by more than 20% in the iterative process, it was reincluded in the model.
Results
During the study period, a total of 306 of 573 patients were enrolled. The main reason for nonparticipation was unavailable 25 (OH) D levels due to technical problems (32% of nonparticipants), while the second most common was death or discharge within 48 h of admission (28%). Malignancy, patient refusal, pregnancy, and known parathyroid dysfunction were other reasons for exclusion.
Baseline characteristics of the subjects are shown in Table 1 . The majority of patients were male (60.5%), with a median (IQR) age of 65.00 (52.00-77.00) years and a median (IQR) SAPS II score of 59 (44.75-77.25).
Furthermore, 42%, 65%, 84%, and 91% of patients had 25 (OH) D levels lower than 5, 10, 15, and 20 ng/mL, respectively. The median 25 (OH) D concentration was 6.31. Significantly lower levels were observed in patients who were female, homebound, or admitted in winter and for emergency surgery, or who had additional cardiovascular, endocrine-metabolic, or neurologic diseases. In contrast, patients who were active before admission, trauma patients, and those admitted in summer had higher levels. Similar differences were seen between 25 (OH) D categorical groups. The differences were more significant in the group with a cutoff point of 5 ng/mL, while in the 20 ng/mL group they were less significant ( Table 2) . Binary logistic regression results showed that being a trauma patient and being admitted during summer decreased the risk of having low 25 (OH) D levels for all categories. However, being female was a risk factor for having 25 (OH) D levels lower than 5, 10, and 15 ng/mL. Lower SAPS II scores and unlimited PLS were associated with levels higher than 5 ng/mL ( Table 3) .
The patients spent a median (IQR) of 11 (5.00-27.25) days in the ICU and 21 (11.00-40.25) days in the hospital. Five patients did not receive mechanical ventilation and 82 received it for less than 48 h. A total of 133 (43.5%) patients died during their ICU stay. Four patients died during their hospital stay after ICU discharge. A total of 160 (52.3%) patients died within 1 year. Sepsis, VAP, and UTI were recorded in 134, 106, and 143 patients, and 88%, 95%, and 75% were seen during the first 28 ICU days, respectively.
The median 25 (OH) D levels were significantly lower in patients with sepsis and VAP during both the 28-day period and the entire ICU period. However, no significant difference was observed between patients with and without UTIs.
Patients who died in the ICU, in the hospital, and over the first year, had significantly lower 25 (OH) D levels ( Table 4) .
According to chi-squared tests, categorical 25 (OH) D groups at different levels showed significant correlations with infection and mortality rates. The highest odds for all infections were seen with 25 (OH) D levels lower than 20 ng/mL, except for those with sepsis, during entire ICU stay. For all mortality rates (ICU, hospital, and 1-year), levels lower than 15 ng/mL had the highest odds (Table 5) .
After adjusting for age, SAPS II, sex, season, comorbidities, PLS scores, and admission diagnosis, the cutoff level of 10 ng/mL was the most statistically significant cutoff value for sepsis during the entire ICU stay. A level of 15 ng/mL was the most significant cutoff for sepsis during the first 28 days and for all UTIs, and 20 Table 5 ). The adjusted ORs for ICU and hospital mortality did not show any significant association with low and high 25 (OH) D levels. Only the 1-year mortality rate was found to be higher in patients with 25 (OH) D deficiency. Among the categories, the OR was highest for the cutoff level of 15 ng/mL (Table 5) . 
Discussion
In the present study, we hypothesized that low levels of 25 (OH) D would be associated with ICU-acquired infections and mortality. Our data showed that the highest odds were seen with levels lower than 20 ng/mL for infections and lower than 15 ng/mL for mortality in univariate analysis. After adjustment for multiple potential confounders, low levels of 25 (OH) D remained significant predictors for infections and 1-year mortality, but not for ICU and hospital mortality. Since the number of patients with 25 (OH) D level higher than 25 ng/mL was limited, we did not compare groups with higher cutoff levels.
Bedridden patients had slightly higher 25 (OH) D levels than homebound patients, and compared with patients with unlimited activity, the adjusted P-value was more significant with homebound than bedridden patients. This could be due to the fact that some bedridden patients received enteral nutritional supplements. Because we did not know whether the patient received nutritional supplements, it is impossible to account for this difference. Not querying about it may be a potential source of bias.
We observed a higher incidence of 25 (OH) D deficiency in critically ill patients than previously reported (10) (11) (12) (13) (14) (15) (16) (17) (23) (24) (25) . However, most of these studies were from developed countries. Studies from developing countries, (26, 27) . The prevalence of hypovitaminosis lower than 5 ng/mL was reported to be as high as 25% in China and Mongolia.
In our cohort, all ICU-related infections and 1-year mortality were associated with low 25 (OH) D levels after adjustment. Among ICU-acquired infections, the most frequently investigated one is sepsis. Jeng et al. showed that 25 (OH) D, vitamin D binding protein (DBP), and cathelicidin (an endogenous antimicrobial peptide) levels were significantly lower in critically ill patients compared to healthy controls, and there was a significant positive association between circulating 25 (OH) D and cathelicidin levels. In a retrospective cohort study with 2399 patients, 25 (OH) D levels lower than 15 ng/mL were associated with blood culture positivity. Cutoff values of 20 and 30 ng/mL were also studied in various cohorts and found to be significantly associated with sepsis (17) (18) (19) (20) (21) (22) (23) (28) (29) (30) (31) (32) (33) .
However, there are conflicting results concerning the association of low 25 (OH) D levels with other nosocomial infections. Some researchers could not find any correlation between nosocomial infections and 25 (OH) D levels, while others observed that low levels of vitamin D were associated with a trend toward increased risk of ICU-acquired infections. However, only a few of these relationships were statistically significant (14, 28, 34) . Mixed results were also reported for mortality rates (4, 17, 27, 35) .
Our results suggest that patients with low vitamin D levels are prone to ICU-related infections, but low vitamin D may be unrelated to mortality rates.
More studies are needed to evaluate the role of vitamin D in ICU-related infections and mortality. Whether replacement therapy leads to better outcomes in the deficient group also needs to be investigated.
